CD8A and neoplasm: The remaining clinico-pathologic variables, mismatch repair, and the stromal or epithelial compartment specific prevalence of CD3+ or CD8+ tumor infiltrating lymphocytes were not associated with the PD-L1 > 10% positive cells cut-point.